About Edelife
Edelife is a company based in Cardiff (United Kingdom) founded in 2021. Edelife offers products and services including ER004. Edelife operates in a competitive market with competitors including NeuroTrax, PTS Granada, MWM Biomodels, Cactus Life Sciences and Orakris, among others.
- Headquarter Cardiff, United Kingdom
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website edelifeclinicaltrial.com
- Legal Name Groupe Pierre Fabre
Products & Services of Edelife
Edelife offers a comprehensive portfolio of products and services, including ER004.
Medicine aimed at replacing missing protein for XLHED treatment in fetuses
Competitors of Edelife
Edelife operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as NeuroTrax, PTS Granada, MWM Biomodels, Cactus Life Sciences and Orakris, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| neurotrax.com | 2000 | Medina, United States | $1.5M | – | Computerized brain wellness monitoring services are provided globally. | |
| ptsgranada.com | 2004 | Granada, Spain | – | – | Research and development spaces in health sciences are provided. | |
| mwm-biomodels.com | 2007 | Munich, Germany | – | – | Biotechnology company that specializes in the development and characterization of transgenic large animal models for scientific research and disease models | |
| cactuslifesciences.com | 2010 | Princeton, United States | – | – | Offers medical communications, scientific strategies, patient engagement, and global biopharma services. | |
| orakris.com | 2008 | Hyderabad, India | – | – | A medical knowledge outsourcing firm providing research and data services to pharmaceutical and healthcare clients. | |
| divigani.lv | 2009 | Ogre, Latvia | – | 3 | Public relations agency for educational projects in health, medicine, and pharmaceuticals sectors. | |
| clininvent.com | 2003 | Hyderabad, India | – | – | Delivers comprehensive pharmaceutical research and manufacturing services to support industry needs. | |
| pharmoutsourcing.com | 2000 | San Francisco, United States | – | – | Provides reviews on business and technology in the pharmaceutical industry. | |
| pulsetech.mx | 2015 | Mexico | – | – | Provides scientific content, creativity, and technology services for health professionals. |
Detailed competitors of Edelife
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Similar companies to Edelife
10 companies that operate in the same segment as Edelife (Cell Therapy), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
CAR T-cell and T-cell receptor immunotherapies for cancer are developed. | 2013 | Seattle, Washington, United States | USD 316.67 M | – | 520 | |
CAR-T and TIL immunotherapies for solid tumors are developed. | 2018 | San Francisco, California, United States | USD 493 M | USD 36 K | 300 | |
T-cell-based immunotherapies for cancer treatment are developed. | 2000 | Tubingen, Baden-wurttemberg, Germany | USD 236.4 M | USD 54.47 M | 423 | |
Engineered T-cell immunotherapies are developed for cancer and auto-immune diseases. | 2015 | London, England, United Kingdom | USD 181.37 M | USD 75.56 M | 647 | |
Smart surgical devices for spinal surgery are developed. | 1997 | San Diego, California, United States | USD 54.1 M | – | – | |
Genetically engineered cell therapies are developed for multiple disorders. | 2018 | Seattle, Washington, United States | USD 821 M | – | 194 | |
Provider of bio-artificial pancreas for Type 1 Diabetes treatment | 2015 | Cambridge, Massachusetts, United States | USD 158 M | – | 58 | |
T-cell and antibody-based therapeutics are developed via single-cell sequencing platforms. | 2011 | San Francisco, California, United States | USD 36.13 M | – | 36 | |
Developer of immune cell therapies | 2019 | San Francisco, California, United States | USD 631.16 M | – | 178 | |
Cue Biopharma is focused on developing immunotherapy solutions. | 2015 | Cambridge, Massachusetts, United States | USD 10 M | USD 27.47 M | 41 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Edelife
Edelife was founded in 2021.
Edelife is headquartered in Cardiff, United Kingdom. It is registered at Cardiff, Wales, United Kingdom.
Edelife is a clinical trial assessing the safety and potential benefits of ER004, an investigational medicine for XLHED, a rare genetic disorder. It involves administering the treatment to pregnant women in their second trimester to potentially improve fetal development of sweat glands, teeth, and skin. The study operates in multiple countries including Germany, UK, and France, with no costs for participants, and focuses on voluntary enrollment through medical centers.
Edelife's top competitors include NeuroTrax, PTS Granada and MWM Biomodels.
Edelife offers ER004.
Edelife operates through Groupe Pierre Fabre.